Your session is about to expire
← Back to Search
Critically ill adults for Oxygen Consumption (TOUCAN-1 Trial)
N/A
Recruiting
Led By Aaron S Hess, MD, PhD
Research Sponsored by University of Wisconsin, Madison
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up through study completion, approximately 20 minutes
Awards & highlights
TOUCAN-1 Trial Summary
The goal of this observational study is to find out if researchers can measure oxygen consumption in the body without having to draw blood from lines in arteries and central veins. Participants will undergo measurements of arterial blood oxygen saturation using both finger and neck pulse oximeters.
TOUCAN-1 Trial Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ through study completion, approximately 20 minutes
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~through study completion, approximately 20 minutes
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Accuracy of digital pulse oximetry
Accuracy of jugular pulse oximetry
TOUCAN-1 Trial Design
1Treatment groups
Experimental Treatment
Group I: Critically ill adultsExperimental Treatment2 Interventions
Inpatient adults who require internal jugular venous central line and radial arterial line
Find a Location
Who is running the clinical trial?
University of Wisconsin, MadisonLead Sponsor
1,190 Previous Clinical Trials
3,169,577 Total Patients Enrolled
Aaron S Hess, MD, PhDPrincipal InvestigatorUniversity of Wisconsin, Madison
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Share this study with friends
Copy Link
Messenger